Filing Details
Camp4 Therapeutics Corp (NASDAQ:CAMP) filed a Form 8-K with the Securities and Exchange Commission on July 27, 2026, disclosing a material event.
8k filedNASDAQ:CAMP
Camp4 Therapeutics Corp (CAMP) Reports Material Event to SEC
Filing Details Camp4 Therapeutics Corp (NASDAQ:CAMP) filed a Form 8-K with the Securities and Exchange Commission on July 27, 2026, disclosing a material event. Market Context…
Market Context
Camp4 Therapeutics Corp's stock currently trades at $3.42 with a market capitalization of $125.7M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Camp4 Therapeutics Corp's stock.
All SEC filings for Camp4 Therapeutics Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CAMP Stock Page
Frequently Asked Questions
Where can I read CAMP's SEC filings?
Browse all filings on our CAMP SEC filings page.
What types of SEC filings does Camp4 Therapeutics Corp file?
Public companies like Camp4 Therapeutics Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.